SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Mostrar otras versiones (1)

All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of generating protective neutralizing antibodies. The recent emergence and rapid spread of several SARS-CoV-2 variants carrying multiple spike mutations raise concerns about possible immune escape. One variant, first...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xiaoying, Tang, Haili, McDanal, Charlene, Wagh, Kshitij, Fischer, William, Theiler, James, Yoon, Hyejin, Li, Dapeng, Haynes, Barton F., Sanders, Kevin O., Gnanakaran, Sandrasegaram, Hengartner, Nick, Pajon, Rolando, Smith, Gale, Glenn, Gregory M., Korber, Bette, Montefiori, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Short Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934674/
https://www.ncbi.nlm.nih.gov/pubmed/33705729
http://dx.doi.org/10.1016/j.chom.2021.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934674/
https://www.ncbi.nlm.nih.gov/pubmed/33705729
http://dx.doi.org/10.1016/j.chom.2021.03.002

Ejemplares similares